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Abstract. 
 
Cells adhere to the substratum through spe-
cialized structures that are linked to the actin cytoskele-
ton. Recent studies report that adhesion also involves 
the intermediate ﬁlament (IF) and microtubule cyto-
skeletons, although their mechanisms of interaction are 
unknown. Here we report evidence for a novel adhe-
sion-dependent interaction between components of the 
actin and IF cytoskeletons. In biochemical fractionation 
experiments, ﬁmbrin and vimentin coprecipitate from 
detergent extracts of macrophages using vimentin- or 
ﬁmbrin-speciﬁc antisera. Fluorescence microscopy con-
ﬁrms the biochemical association. Both proteins colo-
calized to podosomes in the earliest stages of cell adhe-
sion and spreading. The complex is also found in 
ﬁlopodia and retraction ﬁbers. After detergent extrac-
tion, ﬁmbrin and vimentin staining of podosomes, 
ﬁlopodia, and retraction ﬁbers are lost, conﬁrming that 
the complex is localized to these structures. A 1:4 stoi-
chiometry of ﬁmbrin binding to vimentin and a low per-
centage (1%) of the extracted vimentin suggest that 
ﬁmbrin interacts with a vimentin subunit. A ﬁmbrin-
binding site was identiﬁed in the NH
 
2
 
-terminal domain 
of vimentin and the vimentin binding site at residues 
143–188 in the CH1 domain of ﬁmbrin. Based on these 
observations, we propose that a ﬁmbrin–vimentin com-
plex may be involved in directing the assembly of the 
vimentin cytoskeleton at cell adhesion sites.
Key words: ﬁmbrin • vimentin • cytoskeleton • adhe-
sion • microﬁlaments
 
T
 
HE
 
 intricate structure of the microfilament (MF),
 
1
 
microtubule (MT), and intermediate filament (IF)
cytoskeletons is organized by an assortment of ac-
cessory proteins that stabilize or cross-link filaments or at-
tach filaments to the membranes of organelles and the cell
surface (Schliwa, 1986; Bershadsky and Vasiliev, 1988). In
most cases, we know much about the function of the bind-
ing proteins within one cytoskeletal system; for example,
the role of actin cross-linking proteins in bundles and net-
works of actin filaments (Matsudaira, 1991, 1994). In con-
trast, relatively little is known whether or how the coassem-
bly and coorganization of cytoskeletal systems are integrated
and coordinated. The very earliest work used MT and IF
depolymerizing drugs to demonstrate that the organization
of the two cytoskeletal systems are interdependent; the dis-
assembly of one disrupts the pattern of the other (Goldman
and Knipe, 1972; Croop and Holtzer, 1975; Blose and
Chacko, 1976; Wang and Choppin, 1981). More recent stud-
ies have identified several proteins including the IF-associ-
ated protein, plectin, that could serve as physical cross-links
between the different cytoskeletal systems (Svitkina et al.,
1996). In addition to biochemical demonstration of binding,
electron micrographs of cultured fibroblast cells show plec-
tin molecules bridging MTs and vimentin filaments. How-
ever, the story is likely to be more complicated because
plectin is also implicated in interactions with the actin cyto-
skeleton based on the presence of an actin-binding domain
(ABD) in the protein sequence (Wiche et al., 1991, 1993;
Liu et al., 1996). Thus, it is possible that cytoskeletal-binding
proteins may interact with several cytoskeletal systems.
An emerging model is that a superfamily of actin-bind-
ing proteins containing a calponin homology (CH) domain
may play an important integrative function in controlling
the organization of the major cytoskeletal systems in the
cell. In most cases, this CH domain is duplicated to form
the classic ABD of fimbrin, 
 
a
 
-actinin, spectrin, filamin,
dystrophin, other actin cross-linking proteins, and the IF-
binding protein, plectin (Dubreuil, 1991; Hartwig and
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Kwiatkowski, 1991; Otto, 1994). In contrast, a single CH
domain is found at the NH
 
2
 
 terminus of small G-protein
regulatory molecules, 
 
vav
 
 and IQ GAP (Castresana and
Saraste, 1995; Brill et al., 1996). The list of functions attrib-
uted to these proteins implicate the CH domain in cross-
linking MFs into bundles and networks and tethering IF
and signaling proteins to the actin cytoskeleton (Castre-
sana and Saraste, 1995). Thus, CH domain proteins may
directly control the structural organization of the cytoskel-
eton through one or more signaling pathways.
The experiments reported in this paper describe a new
type of interaction between a subunit of the vimentin IF
and an actin cross-linking protein, fimbrin. Fimbrin is a
68-kD actin cross-linking protein associated with actin
bundles (Matsudaira and Burgess, 1979; Bretscher and
Weber, 1980)
 
 
 
in microvilli on the cell surface and in mem-
brane ruffles, microspikes, and cell adhesion sites at the
cell–matrix interface (Bretscher and Weber, 1980; Marchi-
sio et al., 1987; Matsudaira, 1994). Conserved in sequence
from yeast to humans, fimbrin consists of an NH
 
2
 
-terminal
12-kD calcium-binding domain followed by a pair of 27-kD
actin-binding domains (ABD1 and ABD2) (Matsudaira,
1991). Based on sequence and structure from x-ray crystal-
lography, the ABDs consist of a pair of CH domains (de
Arruda et al., 1990; Goldsmith et al., 1997). In mammals,
three fimbrin isoforms are expressed in a tissue-specific
pattern. The intestine-specific isoform, I-fimbrin, is local-
ized to the brush border of intestinal and kidney epithelia
(Lin et al., 1994). In contrast, the leukocyte-specific iso-
form, L-fimbrin, and the general isoform, T-fimbrin, are
localized to cell–substratum adhesion sites in macrophages
and fibroblasts and to the basal surface of differentiating
intestinal enterocytes (Lin et al., 1993; Chafel et al., 1995).
The adhesion site localization of fimbrin is curious be-
cause it does not label the actin bundle of the stress fiber
but instead the site where the bundle is associated with
cell–matrix adhesion proteins. This location at the base of
the cell suggests a different function for the protein, possi-
bly as a component of a cell adhesion complex involved in
establishing cell polarity during embryogenesis. An impor-
tant clue to the mechanism on how fimbrin is targeted to
the base of the cell may be revealed by the identity of pro-
teins that coprecipitated with fimbrin in adherent mac-
rophages (Messier et al., 1993). The results in this paper
show that fimbrin is complexed with vimentin subunits
rather than vimentin filaments and both proteins colocal-
ize at filopodia, retraction fibers, and podosomes on the
ventral surface of cultured macrophages. The association
between the two proteins is adhesion-dependent, implicat-
ing a mechanism that coregulates assembly of the two cy-
toskeletal systems at sites of cell adhesion.
 
Materials and Methods
 
Reagents
 
Unless stated otherwise, cell culture media and supplements were obtained
from GIBCO BRL and reagents were obtained from Sigma Chemical Co.
 
Recombinant Proteins
 
Recombinant vimentin was expressed and purified by published protocols
(Chou et al., 1997). Mutagenesis was carried out on cloned human vimen-
tin in the pTZ18U vector
 
 
 
(Muta-Gene Phagemid In Vitro Mutagenesis kit;
Bio-Rad Laboratories). The 102C vimentin clone was generated by the
deletion of the sequence encoding the NH
 
2
 
 terminus of vimentin and by
the introduction of a new initiation ATG codon immediately preceding
the codon for asparagine-102. For the N410 vimentin clone, a stop codon
was introduced after the codon for isoleucine 410. Both constructs were
subcloned into the PET-7 vector for expression in 
 
Escherichia coli
 
.
For fimbrin expression and purification, BL21(DE3) cells were trans-
formed and the cells were plated onto ampicillin plates. Colonies were in-
oculated into 2 liters of 2
 
3 
 
YT media and shaken for 24 h at 37
 
8
 
C. The
cells were harvested by centrifugation (4,000 rpm for 30 min) and sus-
pended in 50 mM Tris, pH 8.0, 1 mM EDTA, 2 mM DTT, 1 mM PMSF,
and 25% sucrose, and frozen. The cell suspension was thawed, lysed by
sonication, and centrifuged at 18,000 rpm for 30 min. The supernatant was
dialyzed into 10 mM Tris, pH 8.0, 50 mM NaCl, 1 mM EDTA, 1 mM DTT,
0.1 mM PMSF, 1 mM sodium azide and loaded onto a DEAE-Sepharose
fast flow column (Pharmacia Biotech) preequilibrated with the same
buffer. After washing to remove unbound material, the column was eluted
with a linear gradient of NaCl (0–300 mM). Peak fractions were pooled,
concentrated, and loaded onto a Q-Sepharose column (Pharmacia Bio-
tech) that was equilibrated in 10 mM Pipes, pH 7.0, 1 mM EDTA, 50 mM
NaCl, 1 mM DTT, 0.1 mM PMSF, and 0.1 mM sodium azide. The protein
was again eluted with a linear salt gradient (0–300 mM NaCl), pooled, and
loaded onto a Sephacryl S200 HR gel filtration column (Pharmacia Bio-
tech). The purified protein was concentrated on a microconcentrator
(30-kD cut-off).
Glutathione-S-transferase (GST) fusion constructs were generated by
PCR cloning of human L-fimbrin. cDNA regions corresponding to L-fim-
brin protein sequences 97-248, 243-385, 97-188, 97-142, 143-188, and 119-
160 were amplified using synthetic oligonucleotide primers (Life Technol-
ogies, Inc.). A nucleotide tail coding for an in-frame BamHI restriction
site was engineered into each 5
 
9
 
 PCR oligo; a nucleotide tail coding for an
EcoRI restriction site and a downstream amber stop codon (TAG) was
engineered into each 3
 
9
 
 PCR oligo. PCR-amplified DNAs were sub-
cloned, via the engineered BamHI and EcoRI restriction sites, into a
GST-vector, pGEX-4T2 (Pharmacia Biotech), directly downstream of the
GST transcription region. GST-fimbrin fusion proteins were produced by
inducing log phase DH5-
 
a
 
 bacteria containing the GST construct with iso-
propyl-
 
b
 
-
 
D
 
-thiogalactopyranoside for 1.5 h, purifying the recombinant
protein with glutathione agarose beads, and concentrating the eluate with
a centriprep/centricon concentrator (Amicon).
 
Cell Culture
 
The cells used in these experiments were mouse macrophage cell lines
P388D1 (ATCC TIB-63) and IC-21 (ATCC TIB-186). The cell lines were
cultured in 85% RPMI-1640 medium, 15% FBS, and antibiotics (50 IU peni-
cillin and 50 
 
m
 
g/ml streptomycin). Cell culture and maintenance techniques
were performed as described by American Type Culture Collection.
 
Cell Extraction and Immunoprecipitation
 
P388D1 cells were grown to confluence (adherent cells), washed once with
PBS, scraped off the plate in PBS, and pelleted by centrifugation. P388D1
cells were also grown in suspension (nonadherent cells), washed twice in
PBS, and pelleted by centrifugation. The cells were lysed on ice in 10 mM
Pipes buffer, pH 6.8, containing 0.5% Triton X-100, 300 mM sucrose, 100 mM
KCl, 3 mM MgCl
 
2
 
, 10 mM EGTA, 2 mM PMSF, and 50 
 
m
 
M sodium vana-
date (Messier et al., 1993). After 3 min, the cells were centrifuged at
10,000 rpm for 10 min. Aliquots of the supernatant representing the Tri-
ton-extractable fraction were precleared with protein A conjugated to
agarose beads. For immunoprecipitation of fimbrin, the precleared super-
natants were incubated with different antifimbrin sera (736.5, 738.5, 739.5,
and 163.3) or their respective prebleeds for 1 h. For immunoprecipitation
of vimentin, the precleared supernatants were incubated with a combina-
tion of antivimentin sera (Chemicon International, Inc.; Sigma Chemical
Co.). Protein A agarose was added and the extracts incubated for 1 h. The
beads were washed four times with buffer A (0.1% Triton-X 100, 150 mM
NaCl, 10 mM Tris-HCl, pH 8.0) and directly solubilized in the appropriate
buffer for one- or two-dimensional analysis.
 
Two-dimensional Gel Electrophoresis
 
Two-dimensional gel electrophoresis was carried out as described by
O’Farrell et al. (1977). Isoelectric focusing was carried out in the first di- 
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mension by using ampholytes pH 3-10 (Bio-Rad Laboratories), and set-
ting a pH gradient from 4–8. Proteins were resolved in the second dimen-
sion on a 7.5% SDS–polyacrylamide gel. The antifimbrin complex
immobilized on protein A agarose beads was solubilized in SDS-IEF
buffer (0.5% SDS, 9.5 M urea, 2% ampholytes pH 3-10, and 5% 2-mer-
captoethanol). After 10 min, an equal aliquot of Garrel’s buffer (4% NP-
40, 9.5 M urea, 2% ampholytes pH 3-10, and 5% 2-mercaptoethanol) was
added and incubated at 37
 
8
 
C for 15 min. Samples were loaded at the basic
end and allowed to electrophorese for 8,000 Vh. After isoelectric focusing
was complete, the IEF gels were equilibrated in SDS sample buffer, and
then electrophoresed in the second dimension. The gels were finally sil-
ver stained (Shevchenko et al., 1996).
 
Protein Identification
 
The silver-stained spots were excised from the gel, washed, and processed
as described by Shevchenko et al. (1996). The protein was reduced with
10 mM DTT and alkylated with 55 mM iodoacetamide. The gel piece was
finally dried in a Speed-Vac and rehydrated at 4
 
8
 
C in digestion buffer (50 mM
NH
 
4
 
HCO
 
3
 
) containing trypsin (Boehringer Mannheim). Excess trypsin
was removed and the gel incubated overnight at 37
 
8
 
C. Digested peptides
were extracted with 5% formic acid and 50% acetonitrile. The pooled ex-
tracts were dried, dissolved in 5 
 
m
 
l of 5% formic acid and 50% acetoni-
trile, mixed in a 1:1 ratio with either 
 
a
 
-cyano-4-hydroxy-trans-cinnamic
acid or 3,5 dimethoxy-4-hydroxy cinnamic acid (Aldrich Chemical Co.),
and then spotted onto the target plate. All mass spectra were obtained on
the Voyager Elite mass spectrometer (DE-STR; PerSeptive Biosystems)
operated in the reflector mode. A list of monoisotopic peptide masses
(
 
.
 
1,000 and 
 
,
 
3000 Da) was imported into PepFrag and MS-Fit that
searched the Swiss-Prot or GenPept databases. The following parameters
were used in searches: cysteines were modified by aminocarboxymethyla-
tion, proteolytic digestion with trypsin (3–4 incompletes), mass tolerance
of 1 Da, and molecular weight range of 10 kD.
In other experiments, proteolytic fragments of fimbrin and vimentin
were identified by microsequencing of electroblotted fragments following
previously published protocols (Matsudaira, 1987). Peptides were se-
quenced using a microsequencer (model 477A; Applied Biosystems).
 
Overlay Binding Assays
 
The fimbrin and vimentin concentrations were obtained by measuring ab-
sorbance at 280 nm and by SDS-PAGE. Protein was mixed with Sulfo-
NHS-Biotin (Pierce Chemical Co.) at a molar ratio of 1:20 and coupled
following the supplier’s protocol. Unreacted biotin was removed and the
derivatized protein concentrated on a 30-kD cut-off microconcentrator
(Amicon). Typically, 100% of the molecules were derivatized as assayed
by binding to streptavidin-agarose.
The overlay binding assay was performed essentially as described by
Merdes et al. (1991). Electrophoresis of protein samples was performed
in duplicate; one of the gels was stained and the other electroblotted onto
polyvinylidene difluoride (PVDF) (Millipore Corp.). The blot was blocked
with 1% nonfat dry milk in TBST (10 mM Tris-HCl, pH 8.0, 150 mM
NaCl, 0.02% Tween 20) for 1 h. For the fimbrin overlay assay, the blot was
incubated overnight with labeled fimbrin in 1% nonfat dry milk in TBST.
For the vimentin overlay assay, the blot was incubated overnight with
labeled vimentin in 1% nonfat dry milk in a low ionic strength buffer
(8.03 mM NaH
 
2
 
PO
 
4
 
, 1.47 mM KH
 
2
 
PO
 
4
 
, 0.2 mM CaCl
 
2
 
 and 1% Triton
X-100, pH 7.2). The blot was washed with TBST, incubated for 1 h with the
ABC elite vector reagent (Vector Labs, Inc.), washed again with TBST,
and finally developed using the ECL kit (Amersham).
 
In Vitro Binding with Soluble Vimentin
 
Purified vimentin was purchased (Cytoskeleton), whereas recombinant
fimbrin and vimentin were expressed and purified as described above.
Vimentin was kept in an unpolymerized state by disassembling filaments
in 8 M urea, 5 mM sodium phosphate, pH 7.2, 0.2% 2-mercaptoethanol,
and 1 mM PMSF. The sample was dialyzed overnight against 5 mM so-
dium phosphate, pH 7.4, containing 0.2% 2-mercaptoethanol and 0.2 mM
PMSF. The protein concentration was adjusted to 
 
z
 
1 mg/ml and incu-
bated with precleared fimbrin (50 
 
m
 
g each) at 37
 
8
 
C for 1 h in 1 ml of low
ionic strength buffer containing 8.03 mM NaH
 
2
 
PO
 
4
 
, 1.47 mM KH
 
2
 
PO
 
4
 
,
0.2 mM CaCl
 
2
 
 and 1% Triton X-100, pH 7.2. Antifimbrin or preimmune
serum was added and the proteins were incubated for an additional 1 h.
Protein A–Sepharose was added for 1 h and the beads were finally washed
 
three times with buffer A and directly solubilized in SDS–sample buffer.
The samples were resolved on SDS-PAGE, electroblotted onto a PVDF
membrane, and probed with an antivimentin HRP-linked antibody (Af-
finity Biologicals Inc.).
 
Polymerization of Vimentin and Binding Assay
with Fimbrin
 
Vimentin was diluted to a concentration of 0.5 mg/ml in a total volume of
100 
 
m
 
l using assembly buffer (6 mM phosphate buffer, pH 7.4, 3 mM KCl,
0.2% 2-mercaptoethanol, 0.2% PMSF). Polymerization was achieved by
adding 3 
 
m
 
l of 5 M NaCl and incubating at 37
 
8
 
C for 1 h. For cosedimenta-
tion assays, preformed vimentin IFs were incubated for an additional hour
with fimbrin maintained at concentrations from 0.25 to 1 mg/ml. In other
experiments, vimentin and fimbrin were mixed together and IF polymer-
ization, then initiated in the assembly buffer. The proteins were collected
by ultracentrifugation at 100,000 
 
g
 
 for 30 min and analyzed by SDS-
PAGE.
 
Estimation of K
 
d
 
Purified vimentin (2.5 
 
m
 
g) was applied to nitrocellulose membranes. The
blots were placed into wells of a 12-well tissue culture plate (Costar Corp.)
and an overlay assay with labeled fimbrin (0.1–1 
 
m
 
M) was performed as
described earlier. The amount of labeled protein that bound was esti-
mated by densitometric scanning (GS-700 Densitometer; Bio-Rad Labo-
ratories) and quantified using the molecular analyst software (Bio-Rad
Laboratories). Nonspecific binding of biotinylated fimbrin was deter-
mined by measuring the amount of binding to nitrocellulose containing no
vimentin. Specific binding was determined by subtracting nonspecific
binding from the total binding. Scatchard analysis was carried out to esti-
mate the 
 
K
 
d
 
 of binding. Plot shown gives on the vertical axis bound/free
fimbrin and on the horizontal axis bound fimbrin (pmols). The amount of
fimbrin that bound in pmols was obtained from a standard curve of known
amounts of biotinylated fimbrin directly spotted onto nitrocellulose.
 
Fimbrin Proteolysis
 
Small amounts of Lys-C (0.25 
 
m
 
g) were incubated with purified fimbrin
(50 
 
m
 
g) under nondenaturing conditions in 50 
 
m
 
l of 25 mM Tris, pH 7.7,
and 1 mM EDTA. Aliquots were removed at 1, 10, 15, and 30 min,
quenched by the addition of PMSF, and then boiled in SDS–sample
buffer. The digested products were resolved on SDS-PAGE gels that were
either silver stained or electroblotted onto PVDF.
 
Immunofluorescence Microscopy
 
For immunofluorescence studies, cells were allowed to attach onto glass
coverslips (VWR Scientific) for 1–48 h, gently rinsed in PBS, and fixed
with 4% paraformaldehyde (PFA) in PBS for 10 min. After three washes
with PBS, the cells were permeabilized by incubating with 0.1% Triton
X-100 in PBS for 2 min before immunostaining. To prepare detergent-
extracted cells, adherent cells were first incubated with ice-cold 10 mM Pipes
buffer, pH 6.8, containing 0.5% Triton X-100, 300 mM sucrose, 100 mM
KCl, 3 mM MgCl
 
2
 
, 10 mM EGTA, 2 mM PMSF, and 50 
 
m
 
M sodium vana-
date for 3 min, washed with the same buffer, and then fixed with 4% PFA.
Nonspecific protein absorption was inhibited by incubating the cells for
1 h in PBS containing 3% BSA, 0.2% Tween 20, and 0.2% fish gelatin.
Coverslips were incubated for 1 h at 37
 
8
 
C with affinity-purified rabbit–
fimbrin antibody (737.4a) diluted 1:100 and goat–vimentin antibody
(Sigma Chemical. Co.; Chemicon International, Inc.) diluted 1:50. The
coverslips were washed with PBS and the cells were incubated for 1 h at
37
 
8
 
C with secondary antibodies, FITC-conjugated donkey anti–rabbit and
Texas red–conjugated donkey anti–goat (Jackson ImmunoResearch Lab-
oratories). After three washes with PBS, the coverslips were directly
mounted in Vectashield (Vector Labs, Inc.) and examined. Cells exam-
ined for actin distribution were stained with rhodamine phalloidin (Mo-
lecular Probes Inc.).
Cells were imaged by epifluorescence microscopy using a Nikon TE300
microscope with 60 and 100
 
3
 
 oil immersion lenses. The images were re-
corded with a Hammatsu Orca CCD camera and analyzed with the Open
Lab software program (Improvision Inc.). For deconvolution microscopy,
the cells were viewed on a Nikon Eclipse 800 fluorescence microscope
with a 100
 
3
 
 oil immersion lens. Image stacks were recorded at 134-nm in-
tervals (z series) with a Hammatsu Orca CCD camera and analyzed with 
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the CellScan software (Scanalytics) or Metamorph imaging system (Uni-
versal Imaging Corp.) using the exhaustive photon reassignment algo-
rithm. The images were reconstructed in three dimension using either the
acquisition or Imaris software (BitPlane). Colocalized proteins were iden-
tified by using the colocalization algorithm in Imaris, where voxels con-
taining the two different signals were extracted. The images were finally
processed with Adobe Photoshop.
 
Results
 
A Fimbrin–Vimentin Complex in 
Adherent Macrophages
 
In this paper, we investigated the mechanism that targeted
fimbrin to podosomes and filopodia at the cell–substratum
interface of adherent macrophage cells. Because cytoskel-
eton–matrix interactions could involve different sets of
proteins than in the cortical cytoskeleton, our initial exper-
iments examined whether fimbrin is in a precipitable com-
plex with other proteins in adherent macrophage cells.
In Triton-soluble extracts of adherent P388D1 cells, we
found four polypeptides of molecular weights, 45, 55, 68,
and 75 kD that coprecipitated in immune complexes with
four different fimbrin-specific antisera (Fig. 1 A). This in-
teraction with fimbrin is specific, because exogenously
added fimbrin inhibited the immunoprecipitation of the
45, 55, and 75 kD (not shown). Other polypeptides seen on
the gel were also present in immunoprecipitates of the
preimmune sera and, therefore, were not characterized.
Having detected several potential fimbrin-binding pro-
teins, we proceeded to identify them as actin (45 kD), vi-
mentin (55 kD), and the heat shock protein, Hsp70 (75 kD).
Identification was based on a search of sequence data-
bases (PepFrag and MS-FIT) using the tryptic mass finger-
print of each polypeptide and confirmed by immunoblots
using commercially available antisera that are specific for
each protein (not shown). Finally, to confirm that fimbrin
bound the proteins directly we also probed electroblots of
two-dimensional gels with biotinylated fimbrin. On the
blots, fimbrin bound actin, vimentin, and Hsp70 (Fig. 1 B).
Binding to these proteins was inhibited by an excess of un-
labeled fimbrin (not shown). Although Hsp70 appeared to
bind fimbrin with a higher affinity, we studied the fimbrin–
vimentin interaction because of its potential role in modu-
lating the assembly and structure of the actin and IF cy-
toskeletons.
 
Characterization of Fimbrin–Vimentin Binding
 
Because the fimbrin–vimentin complex is found in a Tri-
ton X-100 extract of adherent cells, we also investigated
whether the complex was present in nonadherent cells. Al-
though the total amount of vimentin in adherent and non-
adherent cells is identical, we could immunoprecipitate a
detergent soluble pool of vimentin only from adherent
cells using vimentin-specific antibodies (Fig. 2). Further-
more, a fimbrin-specific antibody detected fimbrin only in
vimentin immunoprecipitates from adherent cells. Recip-
rocal immunoprecipitations with fimbrin-specific antibod-
ies confirmed the presence of an extractable complex in
adherent cells but not in nonadherent cells (not shown).
This extractable fraction of vimentin in adherent cells was
estimated to be 
 
z
 
1% of the total protein.
To understand the nature of the fimbrin–vimentin inter-
action, we first tested whether fimbrin bound preassem-
bled vimentin filaments using a standard high speed pel-
leting assay. However, this assay was unable to detect
fimbrin in pellets of vimentin filaments (not shown). Next,
Figure 1. Identification of fimbrin-binding proteins
present in the Triton X-100 extracts from adherent
P388D1 cells. (A) Proteins immunoprecipitated with fim-
brin antibodies were separated on two-dimensional gels
and detected by silver stain. Four polypeptides of molec-
ular mass 45,000, 55,000, 68,000, and 75,000 Da were pre-
cipitated with fimbrin antisera and were not present in
control antisera. The four proteins were identified from
their tryptic mass fingerprints as actin (45,000), vimentin
(55,000), fimbrin (68,000), and HSP-70 (75,000). Other
polypeptides on the gel were also present in the control
antisera and were not characterized further. (B) In a fim-
brin overlay assay of proteins electroblotted onto PVDF
membranes, only the 45-, 55-, and 75-kD proteins bind
the biotinylated fimbrin probe.
Figure 2. Fimbrin–vimentin complexes in adherent P388D1 cells.
Triton X-100 extracts from adherent and nonadherent cells were
prepared and vimentin immunoprecipitates were probed with vi-
mentin- or fimbrin-specific antibodies. Fimbrin coprecipitated
with vimentin in adherent cells, but was not detected in nonad-
herent cells. The same cells were directly solubilized in sample
buffer, resolved on SDS-PAGE, electroblotted, and probed to
show equivalent amounts of total vimentin. The detergent ex-
tracted pool of vimentin present in adherent cells was estimated
to be z1% of the total vimentin. 
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we tested the binding of fimbrin to unpolymerized vimen-
tin subunits using an immunoprecipitation assay. From a
purified mixture of fimbrin and vimentin, vimentin is de-
tected in immunoprecipitates using a fimbrin antibody and
not in the preimmune serum (Fig. 3 A). To characterize
this interaction more carefully, we measured the binding
of soluble fimbrin to vimentin that was immobilized on ni-
trocellulose membranes. On a Scatchard plot (Fig. 3 B),
we estimated the 
 
K
 
d
 
 of fimbrin binding to vimentin to be
0.25 
 
m
 
M. From the intercept at the x-axis, fimbrin binds
3.8 molecules of vimentin. A simple interpretation of the
data is that fimbrin binds a tetramer of vimentin.
 
Mapping the Fimbrin- and Vimentin-binding Regions
 
Because the binding of fimbrin to unpolymerized vimentin
is a novel finding, we proceeded to investigate whether the
interaction can be localized to discrete domains in both
proteins using proteolytic fragments as well as different
deletion constructs. In an overlay assay (Fig. 4 A), biotin-
Figure 3. Fimbrin binding to unpolymerized vi-
mentin. (A) Under conditions that prevent vi-
mentin polymerization, aliquots from mixtures
of pure recombinant vimentin and fimbrin (50
mg each) were incubated with preimmune serum
(lane 1) or antifimbrin (lane 2) antibodies. When
the immunoprecipitates were probed with an an-
tivimentin antibody, only the fimbrin immuno-
precipitate contained vimentin. (B) The Kd o f
the fimbrin–vimentin interaction was obtained
by dot blot assay and converting the data into a
Scatchard plot. The Kd was calculated to be 0.25
mM and the intercept is at 1:3.8 mole ratio.
Figure 4. CH1 domain of fimbrin binds the NH2 termi-
nus of nonassembled vimentin. (A) In vitro expressed
and purified wild type (WT), COOH-terminally de-
leted (N410) or NH2-terminally deleted (102C) vimen-
tin were resolved on SDS-PAGE, transferred to
PVDF, and probed with labeled fimbrin. Fimbrin binds
wild type (WT) and the COOH-terminally deleted vi-
mentin (N410) but not the NH2-terminal deleted vi-
mentin (102C). (B) Limited proteolysis of fimbrin with
Lys-C and the fragments were detected with silver stain
(lane 1), electroblotted, and probed with biotinylated
vimentin (lane 2). Vimentin bound a 26-kD fragment.
(C) Overlays of fimbrin deletion constructs using bio-
tinylated vimentin. Vimentin bound bands that con-
tained residues 143–188 in the CH1 domain. 
The Journal of Cell Biology, Volume 146, 1999 836
 
ylated fimbrin is shown to bind to full-length unpolymer-
ized vimentin (WT) and vimentin deleted of its COOH
terminus (N410), but does not bind to vimentin deleted of
its NH
 
2
 
 terminus (102C). Similar results were obtained
with an overlay assay of the NH
 
2
 
- and COOH-terminal
fragments of vimentin that were generated by 2-nitro-
5-thiocyanobenzoate cleavage at the single cysteine resi-
due present in the molecule (not shown). Binding between
the two proteins was not affected by the ionic strength of
the assay and comparable levels of binding were detected
in either low (5 mM sodium phosphate) or high (150 mM
NaCl) ionic strength solutions. These results suggest that
fimbrin binds specifically to the NH
 
2
 
-terminal region of vi-
mentin.
To map the vimentin-binding region on fimbrin, we con-
ducted overlay assays on fimbrin proteolyzed with lys-C
(Fig. 4 B). In these experiments, a low ionic strength
buffer was used to keep vimentin from polymerizing. Bio-
tinylated vimentin is seen to specifically bind to a 26-kD
domain of fimbrin. The 26-kD fragment was sequenced
and shown to be part of ABD1. To narrow the vimentin
binding site on actin binding domain 1, we tested binding
of biotinylated vimentin to various truncations of the
ABD1 domain (Fig. 4 C). Using the overlay assay, we
found that vimentin binds any part of the CH1 domain
that contained residues 143–188 (Table I).
 
Immunolocalization of Fimbrin and Vimentin in IC-21 
and P388D1 Cells
 
Because the biochemical experiments strongly suggested
that fimbrin is in a complex with vimentin subunits, we
carried out a series of immunocytological studies to iden-
tify how the proteins were distributed and to determine
where this complex is localized. If fimbrin and vimentin
are in a complex, they should colocalize to the same struc-
tures and compartments in the cell. Using fluorescence mi-
croscopy, we first examined the distribution of filamentous
actin (F-actin) as well as fimbrin and vimentin in two mac-
rophage cell lines; highly differentiated, motile IC-21 cells
and moderately differentiated, nonmotile P388D1 cells. In
nonmotile P388D1 cells, phalloidin staining was localized
in filopodia and cell surface microvilli and the cell body
(Fig. 5 A). However, P388D1 cells do not organize the ac-
tin cytoskeleton into podosomes, and the dotted pattern
characteristic of podosomes was absent in these cells. On
plated IC-21 cells (Fig. 5 B), F-actin is detected in clusters
of small dots, podosomes, or rosette adhesions at the lead-
ing edge of the cell, in the cell body, and in retraction fi-
bers at the trailing end of the cell. This staining pattern is
similar to that observed when primary mouse macro-
phages are stained for actin (Messier et al., 1993). Thus,
the actin cytoskeleton is organized differently in the two
cell lines.
We examined the distribution of fimbrin and vimentin
in the two macrophage cell lines by fluorescence deconvo-
lution microscopy. Double staining of P388D1 cells re-
vealed fimbrin in filopodia and in the perinuclear region of
the cell (Fig. 6 A), whereas vimentin localized to filopodia
and the cell body (Fig. 6 B). To obtain colocalized signals
we imported image stacks for each fluorescent pattern into
an image processing software, Imaris, and voxels (134 nm)
that contained the two signals were extracted and dis-
played in yellow. Fimbrin and vimentin are seen to colo-
calize in the filopodia (Fig. 6 C). In IC-21 cells, fimbrin is
found in podosomes, retraction fibers, and in the perinu-
clear region of the cell (Fig. 6 D), whereas vimentin
stained podosomes, retraction fibers, and the cell body
(Fig. 6 E). The two image stacks were also processed in
Imaris, and voxels containing the two fluorescent signals
(displayed in yellow) show that the proteins colocalized in
podosomes (arrow), retraction fibers, and in the perinu-
clear region (Fig. 6 F). The colocalization of both proteins
on the basal surface was confirmed from side views of a
three-dimensional reconstruction of the cell (not shown).
These results show that fimbrin and vimentin colocalize to
actin-rich structures, filopodia, podosomes, and retraction
fibers in two different macrophage cells.
 
Table I. Summary of Vimentin Binding to Fimbrin Polypeptides
 
Sequence Region of fimbrin Binding
 
Fimbrin
 
1
 
97–248
 
1
 
97–188
 
1
 
97–142
 
2
 
119–160
 
2
 
143–188
 
1
 
243–385
 
2
Figure 5. F-actin distribution
in the two macrophage cell
lines by epifluorescence mi-
croscopy. (A) Nonmotile
P388D1 cells stained with
rhodamine phalloidin show
F-actin staining in filopodia,
cell surface microvilli and the
cell body. (B) Staining of mo-
tile IC-21 cells with rhodamine
phalloidin detected F-actin in
clusters of small adhesions at
the leading edge of the cell,
in the cell body, and in re-
traction fibers at the trailing
end of the cell. 
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Our biochemical studies detected fimbrin and vimentin
in the Triton X-100 extract of IC-21 and P388D1 cells. To
locate those structures that contain this extractable com-
plex, we also examined the distribution of fimbrin and vi-
mentin after Triton X-100 treatment. Before extraction,
the complex was examined on freshly plated cells. Mac-
rophages that had just attached and were beginning to
spread show vimentin and fimbrin staining primarily in the
perinuclear region (not shown). Half an hour after plating,
the two proteins were found in numerous common foci in
regions that were actively spreading (Fig. 7, A–E). How-
ever, the majority of the vimentin network is in the perinu-
clear region. 3 h after plating, the cells were well polarized
and the complex was now restricted to foci in that region
of the cell that was actively expanding and to retraction fi-
bers at the trailing end of the cell (Fig. 8, A–G). After Tri-
ton X-100 extraction, IC-21 cells show complete loss of
staining of fimbrin and vimentin from both retraction fi-
bers and podosomes (Fig. 9, A–D). Similarly, in P388D1
cells, both proteins were less abundant or undetected in
filopodia but were present in the cell body (not shown).
 
Discussion
 
Our studies describe an adhesion-dependent relationship
between the actin and intermediate filament cytoskele-
tons. We present four independent observations that doc-
ument a specific interaction between an actin cross-linking
protein, fimbrin, and an IF protein, vimentin. First, the
two proteins coprecipitate from Triton-X 100–extracted
cells with either fimbrin- or vimentin-specific antibodies.
Second, binding assays with recombinant proteins restrict
the binding region between residues 143–188 of fimbrin
and the head domain of vimentin. Third, the two proteins
Figure 6. Fimbrin–vimentin
localization by deconvolu-
tion microscopy. In P388D1
cells (A–C), immunostaining
with a fimbrin antibody (A)
labeled the filopodia and the
perinuclear region. Immuno-
staining for vimentin (B) in
the same cells localized the
protein in filopodia and in
the cell body. Image stacks
for each of the signals were
imported into an image pro-
cessing software, Imaris, and
reconstructed in three di-
mension. The colocalizing
module in Imaris was used to
extract voxels (134 nm) con-
taining the two signals that
are displayed in yellow. The
two proteins are seen to colo-
calize in filopodia, with some
perinuclear staining (C). In
IC-21 cells (D–F), podo-
somes, perinuclear region,
and retraction fibers at the
trailing end of the cell were
labeled with fimbrin antibod-
ies (D). Immunostaining of
vimentin in the same cells
(E) localized the protein in
the cell body and in retrac-
tion fibers. Using Imaris, the
two proteins are shown to
colocalize in retraction fi-
bers and in podosomes (ar-
row) with some costaining in
the perinuclear region (F). 
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colocalize in podosomes, filopodia, and retraction fibers.
Finally, both proteins are extracted from these structures
by the same detergent treatment. These biochemical and
morphological observations are strong evidence of a fim-
brin–vimentin complex that is found in ventral structures
where a macrophage adheres to the substratum.
The association between fimbrin and vimentin, reported
in this study, is a new finding. Based on previous studies,
fimbrin was shown to bind and cross-link actin filaments.
This function was consistent with its localization in actin
bundles that support cell surface microvilli (Bretscher and
Weber, 1980; Matsudaira, 1991). However, early studies
also detected fimbrin at the cell–matrix interface (Bret-
scher and Weber, 1980; Marchisio et al., 1987), which sug-
gested that fimbrin had a function associated with cell ad-
hesion. This suggestion was reinforced by our finding that
during embryogenesis L-fimbrin is transiently expressed
and localized to the basal surface of embryonic entero-
cytes, whereas T- and I-fimbrin and the majority of F-actin
are in the developing brush border at the apical surface of
the same cells (Chafel et al., 1995). Because IFs are now
recognized components of focal adhesions (Green et al.,
1986; Bershadsky et al., 1987; Geiger et al., 1987; Seifert
et al., 1992), interactions with fimbrin could explain how
vimentin is differentially targeted to cell adhesion struc-
tures where it can assemble into IFs. In addition, associa-
Figure 7. Localization of the fimbrin–vimentin complex in
spreading cells by phase and epifluorescence microscopy. Half
hour after plating, IC-21 cells are seen spreading out in all di-
rections (A). Fimbrin (B and D) and vimentin (C and E) are
detected in common foci in regions of the cell that are actively
spreading. The vimentin network is collapsed around the nu-
cleus. 
Correia et al. 
 
Integrating the Actin and Vimentin Cytoskeleton
 
839
 
tion with vimentin that may be transported to adhesion
sites in a microtubule-dependent mechanism (Prahlad et al.,
1998; Yoon et al., 1998) can explain how fimbrin is tar-
geted to adhesion sites where it can cross-link actin fila-
ments into a bundle.
The fimbrin–vimentin interaction is unusual because
fimbrin binds a vimentin subunit and not a filament. Typi-
cally, cytoskeletal networks are cross-linked by proteins
that bind polymerized filaments (Svitkina et al., 1996;
Yang et al., 1996). For example, elegant immuno EM stud-
ies show plectin cross-bridges between assembled IFs and
MTs (Svitkina et al., 1996). Plectin is also implicated in
binding to actin filaments through an actin-binding do-
main located at the NH
 
2
 
 terminus, whereas the IF-binding
domain is found at the COOH terminus (Wiche et al.,
1993; McLean et al., 1996). However, this is not the case
for fimbrin. Its interaction with a subunit of vimentin is
suggested by the following: the 1:4 stoichiometry of bind-
ing (Fig. 3 B), the absence of substantial fimbrin colo-
calization with vimentin filaments in the cell body, and the
inability of fimbrin to bind polymerized vimentin in pellet-
ing assays (Correia, I., and P. Matsudaira, unpublished
data). The detergent-extracted fraction most likely in-
cludes the pool of unassembled vimentin subunits in the
cell (Soellner et al., 1985) that are believed to be tet-
ramers of vimentin. The identity of the vimentin subunit
as a binding partner of fimbrin is also consistent with
the low percentage (1%) of this species in the superna-
tant (Fig. 2). Thus, the interaction with a vimentin sub-
unit and not a filament suggests that the complex has a
function other than to cross-link the actin and IF cyto-
skeletons.
Binding to vimentin subunits places fimbrin in a unique
position to influence the assembly and organization of
Figure 8. Localization of the fimbrin–
vimentin complex in polarized IC-21
cells. 3 h after attachment, the cells show,
by phase microscopy, an asymmetrical
morphology (A). Using epifluorescence
microscopy the fimbrin–vimentin com-
plex is shown to be restricted to foci
present at the cells leading edge where
the lamella is actively expanding (D
and E). The vimentin network is ex-
tended out in the direction of the lead-
ing edge (C). The fimbrin–vimentin
complex is also detected in retraction
fibers at the trailing end of the cell (F
and G). 
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both the actin and IF cytoskeletons. We speculate that the
fimbrin–vimentin complex plays an early role in the as-
sembly of the actin and vimentin cytoskeleton in filopodia
and podosomes. This speculation is supported by our bio-
chemical observation that the fimbrin–vimentin interac-
tion in P388D1 cells is adhesion-dependent. The time
course of the localization of fimbrin and vimentin in these
structures, obtained by epifluorescence microscopy, also
suggests that the complex is a transient structure that is in-
volved early in cell adhesion. During the early stages of at-
tachment of motile IC-21 cells, we detected costaining of
fimbrin and vimentin in podosomes of expanding lamella.
After 3 h, fimbrin does not become associated with the vi-
mentin network of filaments (Figs. 7 and 8). Because fim-
brin does not bind assembled vimentin filaments in vitro
other proteins may assist in anchoring the vimentin net-
work at mature adhesion sites. These observations are rel-
evant as studies obtained from time-lapse and interference
reflection microscopy indicate a preformed complex of cy-
toskeletal proteins that nucleate the recruitment of adhe-
sive molecules before anchoring the lamellipodia and
filopodia to the substratum (De Pasquale and Izzard, 1987;
Izzard, 1988). Although the compositions of the nucleating
proteins were not described, the fimbrin–vimentin com-
plex is in the right place and at the right time to play this
role.
This model of fimbrin–vimentin function is compatible
with earlier reports from Tao and colleagues (Mabuchi et al.,
1997), who described a similar interaction between desmin
tetramers and calponin in smooth muscle cells. They pro-
posed the idea that an IF subunit and an actin-binding pro-
tein may be involved in the assembly of IFs at dense bod-
ies. We agree with their interpretation. In fact, it is alluring
to consider that the interactions involve cell adhesions. As
discussed in the following section, an interaction between
an IF protein, desmin, or vimentin, and a protein with a
CH domain, calponin, or fimbrin may represent a highly
conserved function that may be related to the establish-
ment of cell adhesion structures.
The fimbrin–vimentin complex is biochemically distin-
guished from the rest of the actin and IF cytoskeletons by
its extraction properties. The critical observation is that
fimbrin and vimentin are extracted from a subset of struc-
tures (podosomes, filopodia, and retraction fibers) by de-
tergent. Biochemical quantitation shows the detergent-
extracted population represents 
 
z
 
1% of the total vimentin
in the cell. Most vimentin is in a detergent-insoluble frac-
tion, and fluorescence microscopy localizes the insoluble
vimentin to filaments in the cell body and around the nu-
cleus. Thus, the vimentin–fimbrin complex found in early
cell adhesion structures is biochemically and structurally
distinct from the vimentin network in the cell body. This
Figure 9. IC-21 cells are extracted
with Triton X-100 before fixation,
and then stained for fimbrin (B and
D) and vimentin protein (A and C).
Cells extracted with detergent show
complete loss of staining for both
proteins in podosomes and retraction
fibers supporting the detergent ex-
tractable nature of the complex in
these two structures. However, the
vimentin network is present in the
cell body after extraction (A). 
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distinction may provide useful approaches for studying the
function of the complex in live cells.
The biochemical and structural properties of the fim-
brin–vimentin complex may be explained by the location
of fimbrin and vimentin binding sites on the proteins. Our
overlay binding assays now tentatively map the region of
fimbrin–vimentin interaction to residues 143–188 of the
NH
 
2
 
-terminal actin-binding domain of fimbrin and the
head domain of vimentin. These sites lie within interesting
regions of both proteins. Fimbrin binds a pair of actin fila-
ments using actin-binding domains that are located in the
NH
 
2
 
- and the COOH-terminal regions of the molecule
(Hanein et al., 1997). Quantitative modeling of a fimbrin
x-ray structure to an EM reconstruction of fimbrin bound
to actin filaments predicts that actin binds fimbrin through
interactions at the two CH domains in the NH
 
2
 
-terminal
actin-binding domain, ABD1 (Hanein et al., 1998). Vi-
mentin also binds fimbrin on ABD1, opposite to the actin-
binding site, but on the same side where the regulatory
calcium-binding domain (residues 1–100) and the COOH-
terminal actin-binding domain (ABD2) are located (Fig.
10). This location poses interesting implications for actin
bundling. Although we have not yet studied the ability of
the fimbrin–vimentin complex to bind and cross-link actin
filaments, we suspect that vimentin binding to fimbrin may
interfere with the ability of fimbrin to cross-link actin.
The fimbrin binding site lies on an important domain of
vimentin. The NH
 
2
 
-terminal domain is absolutely essential
for incorporation of vimentin subunits into protofilaments
and higher order filaments, and deletion of this domain
prevents assembly of vimentin filaments (Traub and Vor-
gias, 1983; Perides et al., 1987; Shoeman et al., 1990; Herr-
mann et al., 1996). Furthermore, phosphorylation of the IF
network on the NH
 
2
 
- and COOH-terminal domains (head
and tail domains) is a well established means for the disas-
sembly of the IF network (Inagaki et al., 1996). Interest-
ingly, preliminary studies carried out in vivo indicate that
the fimbrin–vimentin complex is phosphorylated on vi-
mentin and not on fimbrin (not shown). Although we have
not localized the sites of phosphorylation, fimbrin bound
to the NH2-terminal domain of vimentin may play a role in
regulating vimentin assembly by either directly preventing
incorporation of its subunits into filaments, or indirectly,
by modulating the addition or removal of phosphate
groups.
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